Amb Property Corp (AMB) > Trackbacks

Ambrilia Biopharma Inc.: Ambrilia Announces Positive Results of a Pivotal Human Pharmacokinetic Study of its New Prolonged Release Formulation of Octreotide

Thu, 26 Oct 2006 5:00:00 PDT

MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today positive results of a pivotal pharmacokinetic (PK) study of its lead specialty generic, Octreotide, for the treatment of acromegaly.

Trackbacks

A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Ambrilia Biopharma Inc.: Ambrilia Announces Positive Results of a Pivotal Human Pharmacokinetic Study of its New Prolonged Release Formulation of Octreotide.

No trackbacks have been detected.

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.